1. Home
  2. BRFH vs XLO Comparison

BRFH vs XLO Comparison

Compare BRFH & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barfresh Food Group Inc.

BRFH

Barfresh Food Group Inc.

HOLD

Current Price

$2.90

Market Cap

49.7M

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$0.54

Market Cap

41.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRFH
XLO
Founded
2005
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.7M
41.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BRFH
XLO
Price
$2.90
$0.54
Analyst Decision
Strong Buy
Buy
Analyst Count
1
1
Target Price
$6.00
$2.00
AVG Volume (30 Days)
12.9K
467.9K
Earning Date
11-06-2025
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,574,000.00
$31,804,000.00
Revenue This Year
$37.56
$626.78
Revenue Next Year
$101.44
$79.08
P/E Ratio
N/A
N/A
Revenue Growth
17.49
588.40
52 Week Low
$2.00
$0.54
52 Week High
$6.08
$1.70

Technical Indicators

Market Signals
Indicator
BRFH
XLO
Relative Strength Index (RSI) 40.07 26.05
Support Level $2.96 $0.61
Resistance Level $3.24 $0.63
Average True Range (ATR) 0.16 0.03
MACD -0.03 -0.01
Stochastic Oscillator 7.81 5.70

Price Performance

Historical Comparison
BRFH
XLO

About BRFH Barfresh Food Group Inc.

Barfresh Food Group Inc develops, manufactures and distributes ready to blend frozen beverages, including smoothies, shakes and frappes for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, and without waste. Barfresh provides both a single serve solution and a bulk format solution, ideal for high-volume locations. It has seven flavors available as part of its standard line vanilla shake, caribbean smoothie, triple berry smoothie, caramel macchiato frappe, strawberry banana smoothie, mocha frappe and mango burst smoothie and has the development capabilities to deliver custom flavors.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.

Share on Social Networks: